Delivery Order SPE2DB20D3103-SPE2DB21FL7B4
- Not listed
- The Defense Logistics Agency (DLA) awarded a delivery order contract valued at $15,021.73 to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, to provide a prime vendor pharmaceutical supply service for the DLA Philadelphia branch. The contract is a firm fixed-price delivery order with no set-aside designation, indicating open competition. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which also holds a significant $999,999,999 Indefinite...
- The U.S. Defense Logistics Agency (DLA) awarded a delivery order contract to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, to provide a Prime Vendor Pharmaceutical Branch in Philadelphia. The $8,620.16 firm fixed-price contract has a completion date of May 11, 2021 and was not set aside for any specific business type. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which also holds a $999,999,999 Indefinite Delivery Contract (IDC) with the...
- The U.S. Defense Logistics Agency (DLA) awarded a $45,349.55 Firm Fixed Price delivery order contract to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, to provide a Prime Vendor Pharmacy Branch in Philadelphia. The contract has no set-aside designation and runs through February 2021. Amerisourcebergen is a subsidiary of the parent company Cencora, Inc., which holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical to deliver a comprehensive...
- The Defense Logistics Agency (DLA) awarded a $6,794.43 firm-fixed-price delivery order contract to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, to provide prime vendor pharmaceutical products and medical supplies. This delivery order falls under a larger $999,999,999 Indefinite Delivery Contract (IDC) held by Amerisourcebergen's parent company, Cencora, Inc., with the DLA Troop Support Medical. The IDC serves as the primary vehicle for Amerisourcebergen to deliver a...
- The U.S. Department of Defense's Defense Logistics Agency (DLA) Troop Support Medical awarded a $26,939.38 firm-fixed-price delivery order contract to Amerisourcebergen Drug Corp's Corporate Office division, a major pharmaceutical distributor. This order is part of a broader Indefinite Delivery Contract (IDC) valued up to $999,999,999.00 between Amerisourcebergen and DLA, which serves as the primary vehicle for the company to provide a comprehensive range of pharmaceutical products and medical...
- The U.S. Defense Logistics Agency (DLA) awarded a Delivery Order contract to Amerisourcebergen Drug Corp's Corporate Office Division, valued at $37,007.85, for the supply of pharmaceutical products and medical supplies. This award is under Amerisourcebergen's existing Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, worth up to $999,999,999.00 through December 2025. The IDC enables the DLA to efficiently procure essential medical commodities for the U.S. Armed Forces and...
- The U.S. government's Defense Logistics Agency (DLA) Troop Support Medical awarded a $3,239.07 firm-fixed-price delivery order to Amerisourcebergen Drug Corp's Corporate Office Division, a major pharmaceutical distributor. This order is part of Amerisourcebergen's larger $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA to provide a comprehensive range of pharmaceutical products and medical supplies to support the Department of Defense globally. The contract has no set-aside...
- The U.S. Defense Logistics Agency (DLA) Troop Support Medical awarded a Delivery Order contract valued at $1,778.55 to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of unspecified pharmaceutical products and medical supplies to support federal healthcare programs. This Delivery Order is part of Amerisourcebergen's broader $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for...
- The U.S. Defense Logistics Agency (DLA) Troop Support Medical awarded a $5,576.61 firm-fixed-price delivery order contract to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, to provide a variety of pharmaceutical products and medical supplies. This order is part of Amerisourcebergen's larger $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA to deliver a comprehensive range of medications and critical care materials to support military treatment programs and...
- The U.S. Department of Defense's Defense Logistics Agency (DLA) Troop Support Medical awarded a $2,825.28 delivery order contract to Amerisourcebergen Drug Corp's Corporate Office Division, a major pharmaceutical distributor. This order is part of Amerisourcebergen's $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA to provide a comprehensive range of pharmaceutical products and medical supplies to DLA facilities supporting the Department of Defense worldwide. Amerisourcebergen...
- SPE2DB20D3103Indefinite Delivery Contract
- SPE2DB20D3103-SPE2DB21FL7B4Delivery Order
The Defense Logistics Agency (DLA) awarded a delivery order contract worth $2,328.16 to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, to provide Prime Vendor Pharmaceutical Branch-Philadelphia services. This delivery order is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with the DLA Troop Support Medical, which runs through November 2026. The IDC enables the DLA to efficiently procure a comprehensive range of pharmaceutical products and medical supplies, including specialty medications, brand-name and generic drugs, vaccines, syringes, vials, and test kits, to support military healthcare programs globally. The contract award does not include any set-aside designation, indicating open competition. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which also maintains a separate $750,000 IDC with the Department of Justice Federal Bureau of Investigation for similar medical products and prescription drugs.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.3k | 12/1/20 |